Clinical Trials in Houston

Showing 3421-3440 of 15,366 trials

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

NCT05358821

The primary purpose of this study is to assess the magnitude of the baseline difference between participants with early Huntington's Disease (HD) and healthy participants (HP) with respect to measures of cognitive performance.

Huntington Disease

Supernus Pharmaceuticals, Inc.69 participantsStarted May 2022

Birmingham, Alabama, United States • Los Alamitos, California, United States • Englewood, Colorado, United States +11 more locations

COMPLETED< 1 mile

Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module

NCT03279939

Assessment of image quality and clinical relevance of OCT Angiography via comparison to FA/ICGA.

Retinal VascularNormal Eyes

Heidelberg Engineering GmbH88 participantsStarted Aug 2017

Houston, Texas, United States

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Find Trials by Condition in Houston

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Patient Reported Outcomes With WaveLight Plus LASIK

Histological Evaluation in the Efficacy of GentleWave in Root Canal Pulp Tissue Debridement and Disinfection of Difficult to Reach Areas in Mandibular Human Molars II. An In-vivo Study.

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)

Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma